The loss of p53 function is considered as a primary genetic defect in osteosarcoma; however, many factors within the p53 pathway, including p14ARF, are silenced by promoter hypermethylation in both OS cell lines and 47% of tumor samples [42,43]. This evidence concerns the gene TP53 and neoplasm.